Phytogenic products and phytochemicals as a candidate strategy to improve tolerance to coronavirus

YA Attia, MM Alagawany, MR Farag… - Frontiers in Veterinary …, 2020‏ - frontiersin.org
Coronaviruses are the causative agents of many infectious diseases in human and animals.
These included severe acute respiratory syndrome (SARS), avian infectious bronchitis (IBV) …

A Review of the Ethno-dentistry Activities of Calotropis gigantea

DS Ningsih, I Celik, AH Abas, BM Bachtiar… - Malacca …, 2023‏ - heca-analitika.com
Calotropis gigantea is a medicinal herb that thrives in arid climates. All parts of this plant are
rich in secondary metabolites, which are very beneficial for health. Phytochemicals of this …

The potential of leaf extract of Pangium edule Reinw as HIV-1 protease inhibitor: A computational biology approach

SG Tumilaar, F Fatimawali, NJ Niode… - Journal of Applied …, 2021‏ - japsonline.com
Abstract The leaf of Pangi (Pangium edule) is used as food in North Sulawesi. According to
a study conducted in vitro, Pangi leaf extract suppressed the replication of the human …

[HTML][HTML] The main protease of SARS-CoV-2 as a target for phytochemicals against coronavirus

SS Issa, SV Sokornova, RR Zhidkin, TV Matveeva - Plants, 2022‏ - mdpi.com
In late December 2019, the first cases of COVID-19 emerged as an outbreak in Wuhan,
China that later spread vastly around the world, evolving into a pandemic and one of the …

[HTML][HTML] Optimizing antimicrobial synergy: Green synthesis of silver nanoparticles from Calotropis gigantea leaves enhanced by patchouli oil

P Kemala, K Khairan, M Ramli, Z Helwani… - Narra J, 2024‏ - pmc.ncbi.nlm.nih.gov
Silver nanoparticles (AgNPs) synthesized from plant extracts have gained attention for their
potential applications in biomedicine. Calotropis gigantea has been utilized to synthesize …

Analysis of flavonoid compounds of Orange (Citrus sp.) peel as anti-main protease of SARS-CoV-2: A molecular docking study

NB Maulydia, TE Tallei, B Ginting… - … Series: Earth and …, 2022‏ - iopscience.iop.org
SARS-CoV-2 is a new type of coronavirus that causes COVID-19. This virus was first
detected in the city of Wuhan, China, at the end of 2019, and until now, it has become a …

Potential of betacyanin as inhibitor of SARS-CoV-2 revealed by molecular docking study

TE Tallei, SG Tumilaar, LT Lombogia… - … Series: Earth and …, 2021‏ - iopscience.iop.org
Covid-19 is a global pandemic where an effective drug has yet to be found. A new
coronavirus species, SARS-CoV-2 causes this disease. Several studies have been …

Bioactive compounds from medicinal plants and their possible effect as therapeutic agents against COVID-19: A review

K Khairan, R Idroes, TE Tallei… - Current Nutrition & …, 2021‏ - ingentaconnect.com
Background: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has
infected more than 117 million people worldwide and caused almost 2.6 million deaths …